CSF3R-POLYPEPTIDE UND ANWENDUNGEN DAVON

European patent · EP2046830 · Deleted

Register entry

Publication number
EP2046830
Application number
EP07787134
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Jul 5, 2007
Published
Apr 15, 2009
Granted
Jun 15, 2011
Deleted
Jul 31, 2013
Reason
Annual fee unpaid
IPC classes
C07K 14/715 (2006.01)
C12N 15/12 (2006.01)
Priority
EP 06116704 06.07.2006
US 832177 P 19.07.2006
PCT application
PCT/EP2007/056846 05.07.2007
PCT publication
WO2008/003763 10.01.2008
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Feb 19, 2014

    Deleted, fee unpaid

    Published in Swissreg on 19.02.2014

  2. Jun 24, 2011

    Agent entered

    Representative
    Merck Serono S.A. - Geneva, IP Department, 9, chemin des Mines, 1202 Geneva

    Published in Swissreg on 24.06.2011

  3. Jun 15, 2011

    Granted

    Published in Swissreg on 15.06.2011

Parties

Holder

Merck Serono SA

Centre Industriel, 1267 Coinsins, Vaud

Agent

Merck Serono S.A. - Geneva

IP Department 9, chemin des Mines, 1202 Geneva

Inventor

YORKE-SMITH, Melanie

Guangzhou, Guangdong 510515, CN

PIGNI, Andreas

1227 Carouge

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.